The pharmaceutical industry employs analytical testing to ensure product quality and patient safety. Analytical testing aids in the discovery, development, and manufacturing of drugs by evaluating purity, composition, and potency of pharmaceutical ingredients and final drug products. It helps identify impurities, control manufacturing processes, and release drug products into the market.

The global Pharmaceutical Analytical Testing Market is estimated to be valued at US$ 7.8 billion in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Increasing regulatory requirements to ensure drug safety is propelling the growth of the pharmaceutical analytical testing market. Regulatory agencies like the U.S. Food and Drug Administration (FDA) have stringent regulations for pharmaceutical analytical testing. The FDA requires extensive analytical testing at various stages of drug development and manufacturing to ensure drugs adhere to defined specifications for identity, strength, quality, purity, and stability. Required analytical tests include elemental impurity testing, dissolution testing, finished product testing, stability testing and testing for residual solvents. The growing regulatory scrutiny regarding drug evaluation is forcing pharmaceutical companies to increase investments in analytical testing, which is driving the market growth.

SWOT Analysis
Strength: Pharmaceutical analytical testing helps ensure drug safety and efficacy. It provides quality control and quality assurance.
Weakness: The testing process can be complex and time consuming, increasing costs. There is also a shortage of skilled professionals.
Opportunity: Growing generics market and biologics offer new opportunities. Increased regulations drive more analytical testing needs.
Threats: Outsourcing analytical testing to other regions can be a threat. Economic slowdowns may also decrease R&D spending.

Key Takeaways
The Global Pharmaceutical Analytical Testing Market is expected to witness high growth. The global Pharmaceutical Analytical Testing Market is estimated to be valued at US$ 7.8 billion in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030.

Regional analysis related content comprises Asia Pacific is expected to grow at the fastest rate due to expanding generics production and increasing R&D activities in nations like China, India, and South Korea.

Key players related content comprises Key players operating in the Pharmaceutical Analytical Testing market are Merck KGaA, SGS SA, Eurofins Scientific, Charles River Laboratories International Inc., WuXi AppTec. These companies provide a suite of analytical testing capabilities for pharmaceutical manufacturers worldwide.

For more insights, Read- https://www.pressreleasebulletin.com/pharmaceutical-analytical-testing-market-demand-share-analysis/

Get more insights on this topic: https://shoutingstars.com/code-weavers-bioinformatics-unravelling-the-intricate-thread-of-biological-information-fabric